HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krimo Bouabdallah Selected Research

BEAM regimen

1/2020Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers.
4/2011(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krimo Bouabdallah Research Topics

Disease

19Lymphoma (Lymphomas)
03/2022 - 05/2008
13Hodgkin Disease (Hodgkin's Disease)
01/2022 - 03/2008
12Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2022 - 07/2012
9B-Cell Lymphoma (Lymphoma, B Cell)
10/2022 - 04/2011
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 01/2007
7Neoplasms (Cancer)
02/2022 - 01/2007
4Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2022 - 01/2020
3Residual Neoplasm
06/2022 - 11/2020
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 01/2007
3Pneumonia (Pneumonitis)
01/2021 - 03/2013
3Disease Progression
01/2017 - 07/2012
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2012
2Cytokine Release Syndrome
11/2021 - 01/2021
2Neutropenia
10/2018 - 01/2017
2Pathologic Complete Response
01/2018 - 01/2017
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 12/2012
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2015 - 01/2011
1Macrophage Activation Syndrome
10/2022
1Fatigue
02/2022
1Pain (Aches)
02/2022
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2020
1Infertility (Sterility)
01/2019
1Water Intoxication
06/2018
1Mucositis
06/2018
1Colitis
06/2018
1Gastroenteritis
06/2018
1Chronic Kidney Failure (Chronic Renal Failure)
06/2018
1Hairy Cell Leukemia
01/2018
1Inflammation (Inflammations)
01/2017

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
03/2022 - 01/2007
6obinutuzumabIBA
01/2022 - 08/2013
5Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 01/2020
5Bendamustine HydrochlorideFDA Link
01/2022 - 01/2013
5Etoposide (VP 16)FDA LinkGeneric
01/2021 - 04/2011
4Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2017
4Vinblastine (Vinblastine Sulfate)FDA Link
01/2022 - 01/2018
4NivolumabIBA
01/2022 - 01/2017
4Monoclonal AntibodiesIBA
01/2021 - 01/2007
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 01/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2019
3Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2018
3copanlisibIBA
01/2021 - 12/2017
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2020
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 11/2012
2Chimeric Antigen ReceptorsIBA
06/2022 - 11/2021
2PlatinumIBA
03/2022 - 01/2021
2ibrutinibIBA
03/2022 - 01/2021
2Dacarbazine (DIC)FDA LinkGeneric
01/2022 - 01/2019
2tocilizumab (atlizumab)FDA Link
11/2021 - 01/2021
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 01/2021
2axicabtagene ciloleucelIBA
11/2021 - 01/2021
2Pharmaceutical PreparationsIBA
01/2021 - 01/2014
2Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 01/2019
2Carboplatin (JM8)FDA LinkGeneric
11/2020 - 01/2020
2Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 04/2011
2Carmustine (FIVB)FDA Link
01/2020 - 06/2018
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2020 - 01/2020
2TOR Serine-Threonine KinasesIBA
03/2013 - 07/2012
2Methotrexate (Mexate)FDA LinkGeneric
11/2012 - 01/2011
1brexucabtagene autoleucelIBA
06/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
03/2022
1SaltsIBA
03/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
02/2022
1Antigen Receptors (Antigen Receptor)IBA
01/2021
1venetoclaxIBA
01/2021
1Biological FactorsIBA
01/2021
1OligonucleotidesIBA
01/2021
1Biological ProductsIBA
01/2021
1tirabrutinibIBA
01/2021
16- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA
01/2021
1idelalisibIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2020
1Cisplatin (Platino)FDA LinkGeneric
11/2020
1pembrolizumabIBA
01/2020
1FluorineIBA
01/2020
1Procarbazine (Matulane)FDA Link
01/2019
1Immunotoxins (Immunotoxin)IBA
01/2018
1Epirubicin (Ellence)FDA LinkGeneric
01/2018
1immunotoxin HA22IBA
01/2018
1Protein Isoforms (Isoforms)IBA
12/2017
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2017
1Transferrin (beta 2 Transferrin)IBA
01/2017
1HepcidinsIBA
01/2017
1IronIBA
01/2017

Therapy/Procedure

19Therapeutics
10/2022 - 05/2008
16Stem Cell Transplantation
03/2022 - 12/2008
14Drug Therapy (Chemotherapy)
02/2022 - 07/2012
6Transplantation
11/2020 - 05/2015
5Cell Transplantation
12/2017 - 01/2017
4Radiotherapy
11/2018 - 01/2007
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2017 - 12/2017
2Induction Chemotherapy
11/2020 - 01/2017
2BEAM regimen
01/2020 - 04/2011
2Homologous Transplantation
01/2017 - 01/2011
1Intravenous Infusions
01/2021
1Immunomodulation
01/2020
1Splenectomy
12/2018
1Immunotherapy
12/2018